Youxin Chen is an expert in Ophthalmology at Peking Union Medical College Hospital (China). As of November 2026, ScienceLeadR ranks Youxin Chen in the top 1% of experts worldwide for Retinal Diseases, Diabetic Angiopathies and Diabetes Complications. Youxin Chen has authored 344 publications, the most recent in 2027, and is an investigator in 27 clinical trials, 4 of them ongoing. SLR score: 2,332 (community average: 125). How the SLR is computed.

LeadR Profile

Profile validated by the expert
2 332 ScienceLeadR Reputation 2332
Network Map

Ophthalmology

Subspecialties: Immunology - Biochemistry - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2027
Source: PubMed

Chinese Academy of Medical Sciences & Peking Union Medical College

2012 - 2027

Peking Union Medical College Hospital

1996 - 2027

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 344

Citations

Citations: 5 070 1st author: 11 Last author: 178 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Retinal and choroidal features in patients with diabetic peripheral neuropathy: a stratified analysis by retinopathy status.
PMID 43041727 — eye, peripheral nervous system diseases, choroid, retinaldehyde
Adv Ophthalmol Pract Res20260
Evaluating DeepSeek in Real-World Clinical Scenarios on Performance and Safeguards: Multicenter Comparative Study.
PMID 43024857 — disulfiram, diagnosis, records, medical records
J Med Internet Res20260
Distinguish polypoidal choroidal vasculopathy through choroidal alterations: A systematic review, meta-analysis and narrative synthesis.
PMID 42387875 — eye, macular degeneration, choroid, eye diseases
Acta Ophthalmol20260
Focal hairpin looping of a retinal vein.
PMID 42995709 — retinal vein, eye diseases, retinaldehyde, veins
Eur J Ophthalmol20260
Shared Genetic Architecture Between Myopia and Primary Open-Angle Glaucoma: A Multidimensional Genome-Wide Analysis.
PMID 42929686 — genes, comorbidity, ophthalmology, multiple chronic conditions, glaucoma, open-angle, genome, glaucoma, myopia
Invest Ophthalmol Vis Sci20260

Clinical Studies 27

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 15 Study Chair: 2 Study Director: 1

By phase:

Phase 3 8
Phase 1 6
Phase 2 5
N/A 4
Phase 4 3
Phase 1/Phase 2 1

By status:

Completed 16
Unknown 6
Recruiting 2
Active not recruiting 1
Not yet recruiting 1
Suspended 1

By type:

Interventional 24
Observational 3

By Monocentric/Multicentric:

monocentric 15
multicentric2to4 1
multicentric5to9 2
multicentricup10 9

Main Topics

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Efficacy and Safety of AL 001 Ophthalmic Injection in Subjects with WAMD
NCT06839339 — injections, macular degeneration, vascular endothelial growth factor a, safety, intravitreal injections
Phase 2Not yet recruiting2025
Efficacy and Safety of RC28 E Versus Aflibercept in Diabetic Macular Edema
NCT05885503 — injections, safety, solutions, macular edema, ophthalmic solutions, intravitreal injections, edema
Phase 3Recruiting2023
Clinical Implication of Aflibercept in PCV Treatment in China
NCT05639660 — vascular diseases, therapeutics, prospective studies
N/ARecruiting2021
TAB014 Compared to Lucentis in Patients with Neovascular Age related Macular Degeneration
NCT05461339 — injections, macular degeneration, safety, wet macular degeneration, antibodies, ranibizumab, antibodies, monoclonal, intravitreal injections
Phase 3Active not recruiting2022

LeadR Networks

Main global connection map